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Identity 
Other names: COCA1; FCC1; hMSH2; HNPCC1 
HGNC (Hugo): MSH2 
Location: 2p22-p21 
Local order: Between the FLJ40172 and MSH6 genes. 
DNA/RNA 
Description 
The MSH2 gene is composed of 16 exons spanning in a 
region of 80098 bp. 
Transcription 
The transcribed mRNA has 3145 bp. 
Protein 
Description 
Aminoacids: 934. Molecular Weight: 104.7 kDa.  
MSH2 is a protein involved in the mismatch repair 
process after DNA replication. It contains a DNA 
binding domain and two interaction domains, one for 
MSH3 or MSH6 and the other for MutL homologs 





MSH2 can bind to MSH6 or to MSH3 to form the 
MutS alpha or the MutS beta complexes respectively. 
While MutS alpha complex binds to base-base and 
insertion-deletion mismatches, MutS beta only binds to 
insertion-deletion mismatches. Upon binding to the 
mismatch, the MutS complex associates with the MutL 
complex (composed of MLH1 and PMS2), and recruits 
the proteins needed for DNA excision and repair. (See 
also: Repair of DNA double-strand breaks. 
 
Diagram of the MSH2 gene. Exons are represented by boxes (in scale) transcribed and untranscribed sequences in blue and yellow, with 
exon numbers on top and number of base pairs at the bottom. Introns are represented by black bars (not in scale) and the number of 
base pairs indicated. The arrows show the ATG and the stop codons respectively. 










Diagram of the MSH2 protein in scale. Numbers inside the blue boxes indicate the exon from which is translated each part of the protein. 
The boxes inside represent the DNA binding domain (red), the hMSH3/hMSH6 interaction domain (yellow) and the MutL homologs 
interaction domain (green); C: Carboxyl-terminal; N: Amino-terminal. 
 
Homology 
MSH2 is homologue to the bacterial MutS gene and 
MSH2 homologues are also present in eukaryotes. 
Mutations 
Germinal 
There are over 300 MSH2 germline mutations 
described along the gene that causes hereditary non-
polyposis colorectal cancer (HNPCC, see below). 
Mutations do not occur in any particular hotspot or 
region of the gene and include either nucleotide 
substitutions (missense, nonsense and splicing errors) 
and insertions/deletions (gross or small). In most f 
these mutations the resulting protein is truncated. 
Although rare there are described some founding 
mutations which account for a high proportion of the 
HNPCC tumours in some specific populations. Some 
germline genetic changes have also been described in 
exons and introns as non pathogenic. 
Somatic 
Some sporadic mismatch repair deficient cases 
(sporadic MSI) with somatic MSH2 mutations are 
described. 
Implicated in 
HNPCC (Hereditary Non Polyposis 
Colorectal Cancer) 
Disease 
Predisposition to develop cancer, preferentially 
colorectal, but also in endometrium, urinary tract, 
stomach, small bowel, biliary tract and brain. 
Oncogenesis 
MSH2 mutations in HNPCC account for about 25% of 
the total cases approximately. These mutations are 
inherited in one allele and later the other allele is lost 
by LOH. This leads to mismatch repair deficiency in 
these patients, which is the cause of the accumulation 
of mutations along the genome, causing microsatellite 
instability (MSI) and promoting tumorigenesis. It has 
also been described that low levels of MSI characteize 
MLH1 and MSH2 HNPCC carriers before tumour 
diagnosis. 
 
MSI (MicroSatellite Instability) 
Note 
Tumours in which the molecular feature that leads to 
cancer is the lost of the mismatch repair (MMR) 
system. 
Disease 
This phenotype is present in 15% of colorectal, gastric 
and endometrial cancer, and has a lower incidence i 
some other tissues. 
Prognosis 
MSI tumours have better prognosis than the 
MicroSatellite Stable (MSS). 
Oncogenesis 
Few sporadic cases and about 25% of the HNPCC are 
due to different mutations in MSH2. These mutations 
are germline in HNPCC. 
Muir-Torre syndrome 
Disease 
Coincidence of at least one sebaceous adenoma, 
epithelioma or carcinoma and one internal malignancy. 
Oncogenesis 
Muir-Torre syndrome is mainly due to inherited MSH2 
mutations. 
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